Thank you very much.
Thanks for being here.
I have to carry on with the question about marijuana, and it's really important to me that you understand the impetus behind this. It's coming from multiple letters that I am receiving, not from veterans themselves necessarily but also from caregivers—a lot of times, family members. Their concern is extreme, and they talk very clearly of the difference between their loved one's condition on multiple pharmaceuticals versus using medicinal marijuana.
We know that this is very different from the recreational marijuana that is going to be available to Canadians. It's a totally different product. It does not provide the hallucinations; it provides painkilling. I've been studying it extensively because I want to know what the difference is. These individuals are saying, “You're taking away my loved one, who is finally in a condition where we can talk to each other again.” These are real situations. The reason they've needed the amounts they're talking about is that they don't sit and smoke it. They make creams. They use it in meals, because it absorbs better and you don't destroy your lungs.
What I'm hearing is all very rational. We're prepared to say we're lowering it, but I don't understand what process was taken to determine how that should happen.
When you compare the side effects of being on 1,000 pills a month—and believe me, these women document—we're not dealing with pie-in-the-sky ideas here. They know exactly what they're giving and how much it's costing. For some of them it's $100 per dosage per day. We're talking about the difference in side effects, difference in cost, and the difference in having their loved ones being able to work on other things in their lives because they're no longer in that level of pain.
I don't understand how we came to the decision of three grams. The minister said that he spoke to veterans, but he didn't say how many veterans who are taking medicinal marijuana he spoke to, or how many caregivers. I need more clarification on where we're at with this issue.